Lilly files more lawsuits to curb sales of counterfeit Mounjaro

U.S. drugmaker Eli Lilly (LLY.N) said on Thursday it was suing six more entities including medical spas and wellness centers for selling products claiming to contain tirzepatide, the active ingredient in its popular diabetes drug, Mounjaro.